Skip to main content
Scott Smith, MD, Hematology, Maywood, IL, Loyola University Medical Center

ScottESmithMDPhD, FACP

Hematology Maywood, IL

Hematologic Oncology

Professor of Medicine Section Chief, Hematology Director, Bone Marrow Transplant Loyola University Chicago Stritch School of Medicine

Dr. Smith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Smith's full profile

Already have an account?

Summary

  • Dr. Scott Smith is an oncologist in Maywood, IL and is affiliated with multiple hospitals in the area, including Loyola University Medical Center and Edward Hines, Jr. Veterans Affairs Hospital. He received his medical degree from Wayne State University School of Medicine and has been in practice 21 years. He is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and hematopoietic stem cell transplantation.

Clinical Expertise

  • Hematopoietic stem cell transplantation, Oropharyngeal lymphoma, Cold autoimmune hemolytic anemia, Hairy cell leukemia, Gastric lymphoma, Hematologic oncology, Hodgkin's lymphoma

Education & Training

  • Loyola University Medical Center
    Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2003
  • Loyola University Medical Center
    Loyola University Medical CenterResidency, Internal Medicine, 1996 - 2000
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1996

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 1998 - 2026

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Busulfan, Melphalan, and Bortezomib Compared to Single Agent High-Dose Melphalan As a Conditioning Regimen for Autologous Hematopoietic Stem Cell Transplantation in Mu...
    Scott E. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classi...
    Scott E. Smith, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Loyola Medicine Section Chief of Hematology Available to Discuss Liam Hendriks' Cancer Diagnosis
    Loyola Medicine Section Chief of Hematology Available to Discuss Liam Hendriks' Cancer DiagnosisJanuary 9th, 2023
  • Treating Uninsured Patients Is Wreaking Havoc on Cook County Finances
    Treating Uninsured Patients Is Wreaking Havoc on Cook County FinancesMarch 12th, 2020
  • New Leukemia Drug Is More Effective and Easier to Use
    New Leukemia Drug Is More Effective and Easier to UseJanuary 11th, 2019

Hospital Affiliations